William Blair Investment Management LLC Has $210.96 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

William Blair Investment Management LLC lessened its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 27.1% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 716,967 shares of the biotechnology company's stock after selling 265,858 shares during the period. William Blair Investment Management LLC owned approximately 0.95% of Axon Enterprise worth $210,960,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of AXON. Vanguard Group Inc. increased its stake in Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company's stock valued at $2,547,878,000 after buying an additional 212,401 shares during the period. Sands Capital Management LLC increased its stake in Axon Enterprise by 0.6% during the 4th quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company's stock valued at $679,060,000 after buying an additional 16,347 shares during the period. Norges Bank acquired a new position in Axon Enterprise during the 4th quarter valued at about $195,406,000. Westfield Capital Management Co. LP increased its stake in Axon Enterprise by 5.1% during the 4th quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company's stock valued at $189,025,000 after buying an additional 35,528 shares during the period. Finally, Motley Fool Asset Management LLC increased its stake in Axon Enterprise by 238.7% during the 1st quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company's stock valued at $153,981,000 after buying an additional 346,838 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.

Axon Enterprise Trading Down 1.3 %

Shares of AXON traded down $4.90 during midday trading on Friday, hitting $379.61. The stock had a trading volume of 506,481 shares, compared to its average volume of 520,816. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. The firm has a market cap of $28.69 billion, a P/E ratio of 111.00, a price-to-earnings-growth ratio of 9.69 and a beta of 0.94. The business has a 50-day simple moving average of $338.92 and a two-hundred day simple moving average of $314.65. Axon Enterprise, Inc. has a fifty-two week low of $189.12 and a fifty-two week high of $385.00.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to analysts' expectations of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The firm's quarterly revenue was up 34.5% compared to the same quarter last year. During the same period last year, the company posted $0.80 earnings per share. As a group, equities analysts forecast that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Jefferies Financial Group began coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They set a "buy" rating and a $385.00 target price on the stock. Needham & Company LLC restated a "buy" rating and set a $400.00 price objective on shares of Axon Enterprise in a research report on Wednesday, August 7th. Bank of America began coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They set a "buy" rating and a $380.00 price objective for the company. Barclays raised their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a research report on Wednesday, August 7th. Finally, Craig Hallum raised their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a "buy" rating in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and a consensus target price of $365.38.

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 80,300 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Axon Enterprise news, Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction on Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the transaction, the director now directly owns 4,892 shares of the company's stock, valued at $1,783,916.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The disclosure for this sale can be found here. Over the last three months, insiders sold 316,981 shares of company stock worth $115,281,744. 6.10% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.